File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress

TitleChronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress
Authors
KeywordsEndothelial function
Nitric oxide
NOX1-NOX4
Reactive oxidative species
Sirtuin
Issue Date4-Jul-2023
PublisherOxford University Press
Citation
Cardiovascular Research, 2023, v. 119, n. 12, p. 2190-2201 How to Cite?
Abstract

Aims Enhancing SIRT1 activity exerts beneficial cardiovascular effects. In diabetes, plasma SIRT1 levels are reduced. We aimed to investigate the therapeutic potential of chronic recombinant murine SIRT1 (rmSIRT1) supplementation to alleviate endothelial and vascular dysfunction in diabetic mice (db/db). Methods and results Left internal mammary arteries obtained from patients undergoing coronary artery bypass grafting with or without a diagnosis of diabetes were assayed for SIRT1 protein levels. Twelve-week-old male db/db mice and db/+ controls were treated with vehicle or rmSIRT1 intraperitoneally for 4 weeks, after which carotid artery pulse wave velocity (PWV) and energy expenditure/activity were assessed by ultrasound and metabolic cages, respectively. Aorta, carotid, and mesenteric arteries were isolated to determine endothelial and vascular function using the myograph system. Arteries obtained from diabetic patients had significantly lower levels of SIRT1 relative to non-diabetics. In line, aortic SIRT1 levels were reduced in db/db mice compared to db/+ mice, while rmSIRT1 supplementation restored SIRT1 levels. Mice receiving rmSIRT1 supplementation displayed increased physical activity and improved vascular compliance as reflected by reduced PWV and attenuated collagen deposition. Aorta of rmSIRT1-treated mice exhibited increased endothelial nitric oxide (eNOS) activity, while endothelium-dependent contractions of their carotid arteries were significantly decreased, with mesenteric resistance arteries showing preserved hyperpolarization. Ex vivo incubation with reactive oxygen species (ROS) scavenger Tiron and NADPH oxidase inhibitor apocynin revealed that rmSIRT1 leads to preserved vascular function by suppressing NADPH oxidase (NOX)-related ROS synthesis. Chronic rmSIRT1 treatment resulted in reduced expression of both NOX1 and NOX4, in line with a reduction in aortic protein carbonylation and plasma nitrotyrosine levels. Conclusions In diabetic conditions, arterial SIRT1 levels are significantly reduced. Chronic rmSIRT1 supplementation improves endothelial function and vascular compliance by enhancing eNOS activity and suppressing NOX-related oxidative stress. Thus, SIRT1 supplementation may represent novel therapeutic strategy to prevent diabetic vascular disease.


Persistent Identifierhttp://hdl.handle.net/10722/338253
ISSN
2023 Impact Factor: 10.2
2023 SCImago Journal Rankings: 2.809
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYang, KM-
dc.contributor.authorVelagapudi, S-
dc.contributor.authorAkhmedov, A-
dc.contributor.authorKraler, S-
dc.contributor.authorLapikova-Bryhinska, T-
dc.contributor.authorSchmiady, MO-
dc.contributor.authorWu, XP-
dc.contributor.authorGeng, LL-
dc.contributor.authorCamici, GG-
dc.contributor.authorXu, AM-
dc.contributor.authorLüscher, TF-
dc.date.accessioned2024-03-11T10:27:27Z-
dc.date.available2024-03-11T10:27:27Z-
dc.date.issued2023-07-04-
dc.identifier.citationCardiovascular Research, 2023, v. 119, n. 12, p. 2190-2201-
dc.identifier.issn0008-6363-
dc.identifier.urihttp://hdl.handle.net/10722/338253-
dc.description.abstract<p>Aims Enhancing SIRT1 activity exerts beneficial cardiovascular effects. In diabetes, plasma SIRT1 levels are reduced. We aimed to investigate the therapeutic potential of chronic recombinant murine SIRT1 (rmSIRT1) supplementation to alleviate endothelial and vascular dysfunction in diabetic mice (db/db). Methods and results Left internal mammary arteries obtained from patients undergoing coronary artery bypass grafting with or without a diagnosis of diabetes were assayed for SIRT1 protein levels. Twelve-week-old male db/db mice and db/+ controls were treated with vehicle or rmSIRT1 intraperitoneally for 4 weeks, after which carotid artery pulse wave velocity (PWV) and energy expenditure/activity were assessed by ultrasound and metabolic cages, respectively. Aorta, carotid, and mesenteric arteries were isolated to determine endothelial and vascular function using the myograph system. Arteries obtained from diabetic patients had significantly lower levels of SIRT1 relative to non-diabetics. In line, aortic SIRT1 levels were reduced in db/db mice compared to db/+ mice, while rmSIRT1 supplementation restored SIRT1 levels. Mice receiving rmSIRT1 supplementation displayed increased physical activity and improved vascular compliance as reflected by reduced PWV and attenuated collagen deposition. Aorta of rmSIRT1-treated mice exhibited increased endothelial nitric oxide (eNOS) activity, while endothelium-dependent contractions of their carotid arteries were significantly decreased, with mesenteric resistance arteries showing preserved hyperpolarization. Ex vivo incubation with reactive oxygen species (ROS) scavenger Tiron and NADPH oxidase inhibitor apocynin revealed that rmSIRT1 leads to preserved vascular function by suppressing NADPH oxidase (NOX)-related ROS synthesis. Chronic rmSIRT1 treatment resulted in reduced expression of both NOX1 and NOX4, in line with a reduction in aortic protein carbonylation and plasma nitrotyrosine levels. Conclusions In diabetic conditions, arterial SIRT1 levels are significantly reduced. Chronic rmSIRT1 supplementation improves endothelial function and vascular compliance by enhancing eNOS activity and suppressing NOX-related oxidative stress. Thus, SIRT1 supplementation may represent novel therapeutic strategy to prevent diabetic vascular disease.</p>-
dc.languageeng-
dc.publisherOxford University Press-
dc.relation.ispartofCardiovascular Research-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectEndothelial function-
dc.subjectNitric oxide-
dc.subjectNOX1-NOX4-
dc.subjectReactive oxidative species-
dc.subjectSirtuin-
dc.titleChronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress-
dc.typeArticle-
dc.identifier.doi10.1093/cvr/cvad102-
dc.identifier.pmid37401647-
dc.identifier.scopuseid_2-s2.0-85175188056-
dc.identifier.volume119-
dc.identifier.issue12-
dc.identifier.spage2190-
dc.identifier.epage2201-
dc.identifier.eissn1755-3245-
dc.identifier.isiWOS:001025009300001-
dc.publisher.placeOXFORD-
dc.identifier.issnl0008-6363-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats